Frontlight ResearchEarly access
Trial site
Institute of Hematology, Chinese Academy of Medical Sciences
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Haemophilia1 trial
- Immune thrombocytopenia (ITP)1 trial
- Mantle cell lymphoma1 trial
- Phase
- Phase 32 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 21 trial
- Status
- Active, not recruiting2 trials
- Completed1 trial
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Bisirna Therapeutics (Suzhou) Co., Ltd.1 trial
- Incyte Corporation1 trial
- Pfizer1 trial
- Shanghai IASO Biotechnology Co., Ltd1 trial
- Shanghai Ming Ju Biotechnology Co., Ltd.1 trial
Running trials
Not yet recruiting
Active, not recruiting
A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHD
Recruiting
Active, not recruiting
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell Lymphoma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Immune thrombocytopenia (ITP)1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026